Table 2.
Time-to-Curea (Years) by Cancer Type, Country, and Sex, Estimated in Population-Based Studies
| Europeb,8 | Italyb,11 | France13 | Europe24 | USA99 | Australia26 | ||||
|---|---|---|---|---|---|---|---|---|---|
| M | W | M | W | M | W | M+W | M+W | M+W | |
| Oral cavity and pharynx | 17 | 18 | >20 | >20 | – | ||||
| Oesophagus | 7 | 6 | |||||||
| Stomach | 7 | 8 | 16 | 13 | 10 | 10 | 10 | ||
| Colon/Rectum | 8 | 8 | 10 | 9 | 11 | 9 | 8 | 5–10 | |
| Liver | 20 | 14 | – | 10 | |||||
| Gallbladder | 8 | 7 | |||||||
| Pancreas | 6 | 6 | 8 | 10 | >10 | ||||
| Larynx | >20 | >20 | – | >10 | |||||
| Lung | 9 | 9 | – | ||||||
| Skin melanoma | 6 | 2 | 6 | 6 | 5 | 5 | 7 (M), 2(W) | 2 | 3 |
| Connective tissue | 9 | 12 | 14 | 12 | 7 | 12 | |||
| Breast | 15 | 17 | 11 | >10 | |||||
| Cervix uteri | 4 | 6 | 7 | 4 | 5 | ||||
| Corpus uteri | 7 | 11 | 11 | 10 | 5 | ||||
| Ovary | 10 | 12 | 11 | ||||||
| Prostate | 17 | 17 | 12 | 0 | >10 | ||||
| Testis | <1 | <1 | 0 | 0 | 0 | ||||
| Kidney | 17 | >20 | >20 | >20 | 13 | 12 | |||
| Bladder | 19 | 16 | 16 | 11 | 13 | 12 | >10 | ||
| Thyroid | <1 | <1 | <1 | <1 | 0 | 0 | 0 | 0 | 0 |
| Hodgkin lymphoma | 3 | 2 | 7 | 4 | 3 | ||||
| Non-Hodgkin lymphoma | >20 | >20 | >20 | >20 | |||||
| Multiple myeloma | >20 | >20 | >20 | >20 | |||||
| Leukaemias | >20 | >20 | >20 | >20 | 5c | ||||
Notes: aDefined as time to reach conditional 5-year relative survival >95%. bMore frequent 10-year age group (65–74, 15–44 for melanoma, cervix, testis, thyroid, and Hodgkin lymphoma). cAcute lymphoid leukemias, all ages.